39 results on '"Schroeder, Brock E."'
Search Results
2. Supplemental Figure 5 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
3. Supplemental Table 1 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
4. Supplemental Figure 3 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
5. Supplementary Figures 1-7 from Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
6. Supplemental Figure 2 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
7. Supplemental Figure 1 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
8. Supplemental Table 2 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
9. Supplementary Figures 1-7 from Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
10. Supplementary Tables 1-2 from Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
11. Supplementary Tables 1-2 from Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
12. Supplemental Figure 4 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
13. Response to Grosse and Gudgeon
14. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
15. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
16. Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases
17. The diagnostic trajectory of infants and children with clinical features of genetic disease
18. The Role of Incretins in Insulin Secretion
19. Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis
20. A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
21. Abstract 4744: Clinical validation of a prognostic model integrating Breast Cancer Index (BCI) with tumor size and grade for prediction of late distant recurrence in hormone receptor-positive (HR+) breast cancer with 1-3 positive nodes
22. Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor–Positive Lymph Node–Negative Early-Stage Breast Cancer
23. Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples
24. Abstract P3-06-06: Prediction of benefit from endocrine therapy in ER+ early stage breast cancer: Correlative studies of the breast cancer index HoxB13/IL17BR (H/I) ratio, ER, PR, and HER2 expression in the randomized Stockholm trial
25. Abstract P4-11-19: Integration of breast cancer index (BCI) with clinicopathological factors for prediction of distant recurrence in ER+ breast cancer
26. Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer
27. Abstract B031: Prediction of the clinical benefit of adjuvant tamoxifen therapy using Breast Cancer Index (HOXB13:IL17BR)
28. Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
29. Development and validation of a 32-gene prognostic index for prostate cancer progression
30. Blinded Comparator Study of Immunohistochemical Analysis versus a 92-Gene Cancer Classifier in the Diagnosis of the Primary Site in Metastatic Tumors
31. P2-219: Restorative effects of BDNF gene delivery into entorhinal cortex in APP transgenic mice
32. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
33. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study
34. Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus
35. To Think or Not to Think: Synaptic Activity and Aβ Release
36. Neural Activation Profile Elicited by Cues Associated with the Anxiogenic Drug Yohimbine Differs from That Observed for Reward-Paired Cues
37. Conditioned Fos expression following morphine-paired contextual cue exposure is environment specific.
38. Morphine‐associated environmental cues elicit conditioned gene expression
39. Morphine-associated environmental cues elicit conditioned gene expression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.